Surgical outcomes from the phase 3 CheckMate 816 trial: Nivolumab (NIVO) plus platinum-doublet chemotherapy (chemo) vs chemo alone as neoadjuvant treatment for patients with resectable non-small cell lung cancer (NSCLC).

被引：116

作者：

Spicer, Jonathan

Wang, Changli

Tanaka, Fumihiro

Saylors, Gene Brian

Chen, Ke-Neng

Liberman, Moishe

Vokes, Everett E.

Girard, Nicolas

Lu, Shun

Provencio, Mariano

Mitsudomi, Tetsuya

Awad, Mark M.

Felip, Enriqueta

Forde, Patrick M.

Swanson, Scott

Brahmer, Julie R.

Kerr, Keith

Dorange, Cecile

Cai, Junliang

Broderick, Stephen

机构：

[1] McGill Univ, Hlth Ctr, Montreal, PQ, Canada

[2] Tianjin Med Univ Canc Inst & Hosp, Tianjin Lung Canc Ctr, Tianjin, Peoples R China

[3] Univ Occupat & Environm Hlth, Kitakyushu, Fukuoka, Japan

[4] Charleston Oncol, Charleston, SC USA

[5] Peking Univ, Beijing Canc Hosp, Sch Oncol, Beijing, Peoples R China

[6] Ctr Hosp Univ Montreal, Montreal, PQ, Canada

[7] Univ Chicago Med, Chicago, IL USA

[8] Inst Curie, Inst Thorax Curie Montsouris, Paris, France

[9] Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Shanghai Lung Canc Ctr, Shanghai, Peoples R China

[10] Hosp Univ Puerta Hierro, Madrid, Spain

[11] Kindai Univ, Fac Med, Osaka, Japan

[12] Dana Farber Canc Inst, Boston, MA 02115 USA

[13] Vall dHebron Univ Hosp, Vall dHebron Inst Oncol, Barcelona, Spain

[14] Johns Hopkins Kimmel Canc Ctr, Baltimore, MD USA

[15] Aberdeen Royal Infirm, Aberdeen, Scotland

[16] Bristol Myers Squibb, Princeton, NJ USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 15期

关键词：

D O I：

10.1200/JCO.2021.39.15_suppl.8503

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

8503

引用

页数：3